Sales and Marketing

Showing 15 posts of 11524 posts found.

shutterstock_138095450

Sanofi, Lilly & Novo accused of pricing collusion

November 4, 2016 Manufacturing and Production, Medical Communications, Sales and Marketing

Bernie Sanders has continued his assault on pharma pricing after calling out Eli Lilly earlier this week by implicating Lilly, …
astrazeneca_building_white

AstraZeneca’s post-heart attack drug gets NICE recommendation

November 4, 2016 Medical Communications, Sales and Marketing AstraZeneca, Brillique, NICE, heart attack

AstraZeneca’s Brillique (ticagrelor) has received final recommendation from the National Institute of Health and Care Excellence (NICE) as a prevention …
clinical_trials

Clinical trials and their patients: The rising costs and how to stem the loss

November 3, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials

The pharmaceutical industry has a big problem and it’s one that keeps getting worse every year – how to stop …
nice_reception

NICE approves first new drug for breast cancer in a decade

November 3, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

NICE has approved Eisai’s Halaven (eribulin) for routine treatment of sufferers of locally advanced or metastatic breast cancer that has …
bernie_2

Lily increases diabetes drug by 700% over 20 years

November 3, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Eli Lily, Humalog, diabetes

It has come to light that, over a 20 year period, Eli Lily has increased the price of its diabetes …
merck_and_co

MSD’s Alzheimer’s study could break new ground for treatment

November 3, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, MSD, clinical trials

MSD, known as Merck in North America, has published results of a Phase I trial of verubecestat. The drug is …
fda2outsideweb

FDA issues warning letter after Chinese firm impedes investigation

November 2, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, FDA

The US Food and Drugs Administration (FDA) has issued a Chinese firm with a warning letter after claims it intentionally …
gilead-sciences

Gilead quietly drops drugs from line up alongide Q3 results

November 2, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abzena, Gilead, research and development

Gilead Sciences followed Pfizer in discreetly dropping a drug alongside its third quarter profit reports. The drug in question, for …

Multi Packaging Solutions wins ‘Packaging Company of the Year’

November 2, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Multi Packaging Solutions (“MPS”)(NYSE: MPSX),  a global market leader in healthcare, spirits, confectionery and media packaging, has been voted the …
ibm_web

Celgene partners with IBM for new pharmacovigilance platform

November 2, 2016 Research and Development, Sales and Marketing Celgene, Watson, ibm

IBM is set to join forces with Celgene to develop a new drug safety evaluation platform, it has emerged. Running …
cuba_us_flags

FDA approves clinical trial of Cuban lung cancer vaccine

November 1, 2016 Manufacturing and Production, Sales and Marketing Cuba, US, Vaccine, cimavax, clinical trials

The thawing of relations between the US and Cuba has allowed a pioneering treatment for non-small cell lung cancer to …

EMA has validated Merck and Pfizer’s MAA for avelumab

November 1, 2016 Manufacturing and Production, Sales and Marketing EMA, Merck KGaA, Pfizer, avelumab

The European Medicines Agency has validated the Marketing Authorisation Application for avelumab for the proposed indication of metastatic Merkel cell …
novartis_outside_1

Novartis breast cancer drug secures FDA fast-track status

November 1, 2016 Manufacturing and Production, Sales and Marketing Novartis, Pfizer, ibrance, letrozole, riboclib

Novartis has announced that its product ribociclib (LEE011) has been granted fast-track review status as a first-line treatment of advanced …
marc_weeks_takeda

Takeda appoint Marc Weeks to Digital Lead role

October 31, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, digital

Takeda UK have appointed Marc Weeks to the newly created role of digital lead. The creation of the role comes as …

Ashfield walks away with gold at EVCOM Clarion Awards

October 31, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield

The awards ceremony, held at The Seven Dials Club, Covent Garden, London on Friday 7 October, drew leading event and …
The Gateway to Local Adoption Series

Latest content